{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-014165","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2025-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.164318+00:00","generated_at":"2026-05-26T21:22:40.435179+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Entero Therapeutics terminates CEO James Sapirstein, appoints Richard Paolone as interim CEO","bullets":["James Sapirstein terminated as CEO without cause effective February 12, 2025.","Richard Paolone appointed interim CEO and Chairman, effective immediately.","Paolone is a Toronto securities lawyer with board seats at multiple public companies.","Paolone ceases to be independent director; Eric Corbett joins audit, governance, and compensation committees.","Paolone's compensation as interim CEO to be determined at a later date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-014165","json":"https://secwatch.observer/filing/0001104659-25-014165.json","markdown":"https://secwatch.observer/filing/0001104659-25-014165.md","text":"https://secwatch.observer/filing/0001104659-25-014165.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/0001104659-25-014165-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/tm256561d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T21:22:40.435179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17f669daf4","claim":"Richard Joel Paolone was appointed as Interim Chief Executive Officer and Chairman of the Board at GridAI Technologies Corp..","evidence_excerpt":"On February 12, 2025, Richard Joel Paolone was appointed to serve as Interim Chief Executive Officer of the Company and Chairman of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/0001104659-25-014165-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer and Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"f8aa5090a6","claim":"James Sapirstein was terminated as Chief Executive Officer at GridAI Technologies Corp..","evidence_excerpt":"On February 12, 2025, the Board of Directors (the “Board”) of Entero Therapeutics, Inc. (the “Company”) terminated James Sapirstein as Chief Executive Officer of the Company, without cause, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925014165/0001104659-25-014165-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}